Raymond James & Associates Senseonics Holdings, Inc. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 19,800 shares of SENS stock, worth $8,316. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,800

Previous 19,700 0.51%

Holding current value

$8,316

Previous $7,000 14.29%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$0.32 - $0.49 $32 - $49	100 Added 0.51%	19,800 $6,000
Q2 2024 Jul 19, 2024	SELL	$0.37 - $0.52 $2,542 - $3,573	-6,872 Reduced 25.86%	19,700 $7,000
Q1 2024 Apr 22, 2024	BUY	$0.5 - $0.73 $5,936 - $8,666	11,872 Added 80.76%	26,572 $14,000
Q3 2023 Oct 24, 2023	SELL	$0.5 - $1.05 $567 - $1,191	-1,135 Reduced 7.17%	14,700 $8,000
Q2 2023 Jul 25, 2023	BUY	$0.55 - $0.89 $770 - $1,246	1,400 Added 9.7%	15,835 $12,000
Q3 2022 Oct 25, 2022	BUY	$1.02 - $2.23 $102 - $223	100 Added 0.7%	14,435 $19,000
Q2 2022 Aug 12, 2022	BUY	$0.94 - $1.94 $13,474 - $27,809	14,335 New	14,335 $15,000
Q2 2021 Aug 11, 2021	SELL	$1.71 - $4.14 $93,217 - $225,683	-54,513 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$0.85 - $5.27 $703,569 - $4.36 Million	-827,729 Reduced 93.82%	54,513 $144,000
Q4 2020 Feb 12, 2021	SELL	$0.36 - $0.95 $47,100 - $124,292	-130,834 Reduced 12.91%	882,242 $769,000
Q3 2020 Nov 04, 2020	SELL	$0.36 - $0.53 $12,060 - $17,755	-33,500 Reduced 3.2%	1,013,076 $392,000
Q2 2020 Jul 28, 2020	SELL	$0.39 - $0.69 $3,900 - $6,899	-10,000 Reduced 0.95%	1,046,576 $408,000
Q1 2020 Apr 21, 2020	SELL	$0.56 - $1.62 $5,936 - $17,172	-10,600 Reduced 0.99%	1,056,576 $669,000
Q4 2019 Feb 12, 2020	SELL	$0.83 - $1.3 $32,370 - $50,700	-39,000 Reduced 3.53%	1,067,176 $978,000
Q3 2019 Nov 07, 2019	BUY	$0.97 - $1.94 $31,161 - $62,322	32,125 Added 2.99%	1,106,176 $1.09 Million
Q2 2019 Aug 06, 2019	BUY	$1.81 - $2.45 $295,218 - $399,604	163,104 Added 17.9%	1,074,051 $2.19 Million
Q1 2019 May 06, 2019	BUY	$2.3 - $3.27 $141,410 - $201,049	61,483 Added 7.24%	910,947 $2.23 Million
Q4 2018 Feb 11, 2019	BUY	$2.49 - $4.54 $52,705 - $96,098	21,167 Added 2.56%	849,464 $2.2 Million
Q3 2018 Nov 14, 2018	BUY	$3.4 - $4.84 $1.08 Million - $1.53 Million	316,623 Added 61.88%	828,297 $3.95 Million
Q2 2018 Aug 14, 2018	BUY	$3.03 - $4.98 $1.39 Million - $2.29 Million	459,274 Added 876.48%	511,674 $2.1 Million
Q1 2018 May 14, 2018	BUY	$2.48 - $3.21 $49,352 - $63,879	19,900 Added 61.23%	52,400 $157,000
Q4 2017 Feb 14, 2018	BUY	$2.43 - $3.54 $1,215 - $1,770	500 Added 1.56%	32,500 $86,000
Q3 2017 Nov 13, 2017	SELL	$2.22 - $3.2 $15,540 - $22,400	-7,000 Reduced 17.95%	32,000 $102,000
Q2 2017 Aug 14, 2017	BUY	N/A	39,000	39,000 $70,000

Others Institutions Holding SENS

# of Institutions

156

Shares Held

145M

Call Options Held

588K

Put Options Held

299K

View Full List

About Senseonics Holdings, Inc.

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $195M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

More about SENS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Senseonics Holdings, Inc. Transaction History